Burden of gluteal fibrosis and post-injection paralysis in the children of Kumi District in Uganda
- PMID: 30249239
- PMCID: PMC6154889
- DOI: 10.1186/s12891-018-2254-9
Burden of gluteal fibrosis and post-injection paralysis in the children of Kumi District in Uganda
Abstract
Background: The purpose of this study was to estimate the prevalence of postinjection paralysis (PIP) and gluteal fibrosis (GF) among children treated in a rural Ugandan Hospital.
Methods: We conducted a retrospective cohort study by reviewing the musculoskeletal clinic and community outreach logs for children (age < 18 yrs) diagnosed with either PIP or GF from Kumi Hospital in Kumi, Uganda between 2013 and 2015. We estimated the prevalence as a ratio of the number of children seen with each disorder over the total population of children seen for any musculoskeletal complaint in musculoskeletal clinic and total population of children seen for any medical complaint in the outreach clinic.
Results: Of 1513 children seen in the musculoskeletal clinic, 331 (21.9% (95% CI 19.8-24.1%)) had PIP and another 258 (17.1% (95% CI 15.2-19.0%)) had GF as their diagnosis. Of 3339 children seen during outreach for any medical complaint, 283 (8.5% (95% CI 7.6-9.5%)) had PIP and another 1114 (33.4% (95% CI 31.8-35.0%)) had GF. Of patients with GF, 53.9% were male with a median age of 10 years (50% between 7 and 12 years old). Of patients with PIP, 56.7% were male with a median age of 5 years (50% between 2 and 8 years old).
Conclusion: PIP and GF comprise over 30% of clinical visits for musculoskeletal conditions and 40% of outreach visits for any medical complaint in this area of Uganda. The high estimated prevalence in these populations suggest a critical need for research, treatment, and prevention.
Keywords: Gluteal fibrosis; Post-injection paralysis.
Conflict of interest statement
Ethics approval and consent to participate
The study was approved by a local Institutional Review Board in Uganda and the Uganda National Council for Science and Technology as well as the senior author’s (CSS) institutional IRB (UCSF). The study was found by all institutions to be exempt from requiring consent.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- World Health Organization . Safety of injections: a brief background. Fact sheet No. 231. Geneva: WHO; 1999.
-
- World Health Organization Unsafe injection practice and transmission of blood borne pathogens. WHO Bull. 1999;77:787–799.
-
- Chung D, Ko Y, Pai H. A study on the prevalence and risk factors of muscular fibrotic contracture in Jia-dong township, Pingtung County, Taiwan. Gaoxiong Yi Xue Ke Xue Za Zhi. 1989;5:91–95. - PubMed
-
- Ekure J. Gluteal fibrosis. A report of 28 cases from Kumi hospital, Uganda. East and Central African Journal of Surgery. 2006;12:144–147.
-
- Ko Y, Chung D, Pal H. Intramuscular-injection associated gluteal fibrotic contracture and hepatitis B virus infection among school children. Gaoxiong Yi Xue Ke Xue Za Zhi. 1991;7:358–362. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
